BACKGROUND AND OBJECTIVE: Poly(adenosine diphosphate [ADP]-ribose) polymerase 1 (PARP1), a protein involved in the DNA repair mechanism, plays an important role in carcinogenesis. In this study, we investigated whether single nucleotide polymorphisms of PARP1 contribute to gastric cancer (GC) and its precursor lesions (gastric precancerous lesions; GPL) in a case-control study conducted in the Hexi area of China, a high-risk area for GC. METHODS: PARP1 162C>G (Phe54Leu) and 2819A>G (Lys940Arg) polymorphisms were genotyped by real-time PCR using a TaqMan assay in 140 GC cases, 110 GPL cases, and 120 controls. Data were statistically analyzed using the chi-squared test and a logistic regression model. RESULTS: The presence of the PARP1 2819G allele was associated with an increased risk of GC (odds ratio [OR] 2.354; 95% CI 1.140, 4.861; p = 0.018), especially for cardia GC and diffuse-type GC (ORs 2.988 and 3.784, respectively). We also observed an interaction between Helicobacter pylori infection, GC family history, and the presence of the PARP1 2819G allele. In contrast, the PARP1 162C>G polymorphism was not significantly associated with GPL or GC. CONCLUSION: The study suggests that the PARP1 2819G allele is associated with an increased risk of GC. In addition, H. pylori-positive status and family history jointly contribute to a higher risk of GC.
BACKGROUND AND OBJECTIVE: Poly(adenosine diphosphate [ADP]-ribose) polymerase 1 (PARP1), a protein involved in the DNA repair mechanism, plays an important role in carcinogenesis. In this study, we investigated whether single nucleotide polymorphisms of PARP1 contribute to gastric cancer (GC) and its precursor lesions (gastric precancerous lesions; GPL) in a case-control study conducted in the Hexi area of China, a high-risk area for GC. METHODS: PARP1 162C>G (Phe54Leu) and 2819A>G (Lys940Arg) polymorphisms were genotyped by real-time PCR using a TaqMan assay in 140 GC cases, 110 GPL cases, and 120 controls. Data were statistically analyzed using the chi-squared test and a logistic regression model. RESULTS: The presence of the PARP1 2819G allele was associated with an increased risk of GC (odds ratio [OR] 2.354; 95% CI 1.140, 4.861; p = 0.018), especially for cardia GC and diffuse-type GC (ORs 2.988 and 3.784, respectively). We also observed an interaction between Helicobacter pyloriinfection, GC family history, and the presence of the PARP1 2819G allele. In contrast, the PARP1 162C>G polymorphism was not significantly associated with GPL or GC. CONCLUSION: The study suggests that the PARP1 2819G allele is associated with an increased risk of GC. In addition, H. pylori-positive status and family history jointly contribute to a higher risk of GC.
Authors: K H Lee; J H Lee; J K Cho; T W Kim; Y K Kang; J S Lee; W K Kim; J G Chung; I C Lee; H S Sun Journal: Pathol Res Pract Date: 2001 Impact factor: 3.250
Authors: Kristin L Lockett; M Craig Hall; Jianfeng Xu; S Lilly Zheng; Marianne Berwick; Shu-Chun Chuang; Peter E Clark; Scott D Cramer; Kurt Lohman; Jennifer J Hu Journal: Cancer Res Date: 2004-09-01 Impact factor: 12.701
Authors: Carlos W Nossa; Prashant Jain; Batcha Tamilselvam; Vijay R Gupta; Lin-Feng Chen; Valérie Schreiber; Serge Desnoyers; Steven R Blanke Journal: Proc Natl Acad Sci U S A Date: 2009-11-06 Impact factor: 11.205
Authors: Andreína Peralta-Leal; José Manuel Rodríguez-Vargas; Rocío Aguilar-Quesada; María Isabel Rodríguez; José Luis Linares; Mariano Ruiz de Almodóvar; F Javier Oliver Journal: Free Radic Biol Med Date: 2009-04-10 Impact factor: 7.376
Authors: A C de Vries; G A Meijer; C W N Looman; M K Casparie; B E Hansen; N C T van Grieken; E J Kuipers Journal: Gut Date: 2007-08-14 Impact factor: 23.059
Authors: Maria Peña-Chilet; Maite Blanquer-Maceiras; Maider Ibarrola-Villava; Conrado Martinez-Cadenas; Manuel Martin-Gonzalez; Cristina Gomez-Fernandez; Matias Mayor; Juan Antonio Aviles; Ana Lluch; Gloria Ribas Journal: BMC Cancer Date: 2013-03-27 Impact factor: 4.430